Implemented by the AEBR on behalf of DG SANTE, it analysed cross-border patient flows in the cross-border regions across the triple border of Germany, Belgium and the Netherlands (Meuse-Rhine), Grand Est Region (France) and Luxembourg, Lower Austria with the Czech Republic and Slovakia, and the general patient flow between Poland and Czechia.
This study has found that there is a lack of data, or they are inconsistent, making it thus difficult to assess the impact of cross-border healthcare under the Directive.
It makes a number of recommendations to improve patient mobility data involving national and regional authorities, healthcare insurers and other stakeholders. Here you will find the Final Report and the Executive Summary (in EN, FR, DE, NL, CZ and PL) on the website of the European Commission, but you can also find them in AEBR’s virtual library.
The findings provide evidence for the Commission’s ongoing work to evaluate the Directive’s impact on patients seeking cross-border healthcare in the neighbouring country.Back to overview